{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:36:48Z","timestamp":1787330208462,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205174\/Z\/16\/Z"],"award-info":[{"award-number":["205174\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"award":["205174\/Z\/16\/Z"],"award-info":[{"award-number":["205174\/Z\/16\/Z"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa and cataracts) syndrome is a rare neurodegenerative inherited disorder characterized by a spectrum of these clinical phenotypes. Due to the considerable heterogeneity in the age of onset of the different clinical features and the similarities with other conditions, it is often misdiagnosed. Variants in the ABHD12 gene have been identified as a genetic cause of PHARC syndrome and are predicted to result in loss-of-function or severely reduced protein synthesis. ABHD12 (\u03b1\/\u03b2-hydrolase domain-containing protein 12) is responsible for the breakdown of very-long-chain lysophosphatidylserines (VLC-lyso-PS). When ABHD12 is dysfunctional, VLC-lyso-PS accumulates in the brain, producing inflammation. In this study, the clinical phenotypes of five patients with molecularly confirmed ABHD12 pathogenic variants from Moorfields Eye Hospital together with those of 64 patients reported in the literature were analyzed to investigate genotype\u2013phenotype correlations. We report a novel variant c.985del p.(His329Thrfs*57) associated with PHARC syndrome. Moreover, patients with two null variants in ABHD12 manifest more of the clinical features of PHARC syndrome than those with at least one missense variant. Our study shows the importance of a complete clinical and genetic diagnosis to enable accurate diagnosis and genetic counselling for affected individuals.<\/jats:p>","DOI":"10.3390\/ijms27167506","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:51:05Z","timestamp":1787327465000},"page":"7506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of ABHD12 Variants with the Spectrum of PHARC Syndrome Phenotypes"],"prefix":"10.3390","volume":"27","author":[{"given":"Sara","family":"Romero-V\u00e1zquez","sequence":"first","affiliation":[{"name":"UCL Institute of Ophthalmology, London EC1V 9EL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"M\u00e9j\u00e9case","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, London EC1V 9EL, UK"},{"name":"The Francis Crick Institute, London NW1 1AT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catalina","family":"Rodriguez-Martinez","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, London EC1V 9EL, UK"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-2608","authenticated-orcid":false,"given":"Nicola","family":"Cronbach","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, London EC1V 9EL, UK"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-5360","authenticated-orcid":false,"given":"Mariya","family":"Moosajee","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, London EC1V 9EL, UK"},{"name":"The Francis Crick Institute, London NW1 1AT, UK"},{"name":"Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2010.08.002","article-title":"Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism","volume":"87","author":"Fiskerstrand","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1750-1172-7-59","article-title":"Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3","volume":"7","author":"Eisenberger","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.ophtha.2014.02.008","article-title":"Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: From syndromic to nonsyndromic retinal degeneration","volume":"121","author":"Nishiguchi","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00439-022-02448-7","article-title":"The genetic and phenotypic landscapes of Usher syndrome: From disease mechanisms to a new classification","volume":"141","author":"Delmaghani","year":"2022","journal-title":"Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000333664.90605.23","article-title":"A novel Refsum-like disorder that maps to chromosome 20","volume":"72","author":"Fiskerstrand","year":"2009","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.1217121110","article-title":"ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC","volume":"110","author":"Blankman","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nchembio.1721","article-title":"Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay","volume":"11","author":"Kamat","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/acs.biochem.0c00349","article-title":"Mapping the neuroanatomy of ABHD16A-ABHD12 and lysophosphatidylserines provides new insights into the pathophysiology of the human neurological disorder PHARC","volume":"59","author":"Singh","year":"2020","journal-title":"Biochemistry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16953","DOI":"10.1074\/jbc.RA118.005640","article-title":"Biochemical characterization of the PHARC-associated serine hydrolase ABHD12 reveals its preference for very-long-chain lipids","volume":"293","author":"Joshi","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00726-018-2682-8","article-title":"Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease","volume":"51","author":"Kind","year":"2019","journal-title":"Amino Acids"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acs.biochem.4c00865","article-title":"Bioinformatics Analysis Identifies Sequence Determinants of Enzymatic Activity for the PHARC-Associated Lipase ABHD12","volume":"64","author":"Chakraborty","year":"2025","journal-title":"Biochemistry"},{"key":"ref_13","first-page":"792","article-title":"Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism","volume":"1831","author":"Lord","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1021\/acs.jmedchem.1c00624","article-title":"\u03b1\/\u03b2-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases","volume":"64","author":"Bononi","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41589-018-0195-0","article-title":"A chemical\u2013genetic screen identifies ABHD12 as an oxidized-phosphatidylserine lipase","volume":"15","author":"Kelkar","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1111\/ejn.15516","article-title":"The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation","volume":"54","author":"Singh","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1007\/s11064-021-03425-8","article-title":"Increase in Cellular Lysophosphatidylserine Content Exacerbates Inflammatory Responses in LPS-Activated Microglia","volume":"47","author":"Minamihata","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.chembiol.2021.01.008","article-title":"Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs","volume":"28","author":"Khandelwal","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Leishman, E., Mackie, K., and Bradshaw, H.B. (2019). Elevated levels of arachidonic acid-derived lipids including prostaglandins and endocannabinoids are present throughout ABHD12 knockout brains: Novel insights into the neurodegenerative phenotype. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00142"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/dneu.22572","article-title":"Cerebellar microglia are dynamically unique and survey Purkinje neurons in vivo","volume":"78","author":"Stowell","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jns.12367","article-title":"Genotype-phenotype correlation in a novel ABHD12 mutation underlying PHARC syndrome","volume":"25","author":"Thimm","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nguyen, A.X.T., Almushattat, H., Strubbe, I., Georgiou, M., Li, C.H.Z., van Schooneveld, M.J., Joniau, I., De Baere, E., Florijn, R.J., and Bergen, A.A. (2021). The phenotypic spectrum of patients with pharc syndrome due to variants in ABHD12: An ophthalmic perspective. Genes, 12.","DOI":"10.3390\/genes12091404"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/13816810.2021.1946704","article-title":"Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome","volume":"42","author":"Igelman","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/MAO.0000000000003706","article-title":"Clinical Impact of Genetic Diagnosis of Sensorineural Hearing Loss in Adults","volume":"43","author":"Aguado","year":"2022","journal-title":"Otol. Neurotol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jns.2018.02.021","article-title":"Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene","volume":"387","author":"Frasquet","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jns.12216","article-title":"A complex homozygous mutation in ABHD12 responsible for PHARC syndrome discovered with NGS and review of the literature","volume":"22","author":"Lerat","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/humu.22437","article-title":"Two Novel Mutations in ABHD12: Expansion of the Mutation Spectrum in PHARC and Assessment of Their Functional Effects","volume":"34","author":"Chen","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gene.2019.04.008","article-title":"A novel ABHD12 nonsense variant in Usher syndrome type 3 family with genotype-phenotype spectrum review","volume":"704","author":"Li","year":"2019","journal-title":"Gene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2016.11.008","article-title":"Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC","volume":"98","author":"Lavie","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1177\/0003489415574513","article-title":"Novel ABHD12 Mutations in PHARC Patients","volume":"124","author":"Yoshimura","year":"2015","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mdc3.13266","article-title":"PHARC Syndrome, a Rare Genetic Disorder\u2014Case Report","volume":"8","author":"Bastos","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Daneshi, A., Garshasbi, M., Farhadi, M., Falavarjani, K.G., Vafaee-Shahi, M., Almadani, N., Zabihi, M., Ghalavand, M.A., and Falah, M. (2023). Genetic insights into PHARC syndrome: Identification of a novel frameshift mutation in ABHD12. BMC Med. Genom., 16.","DOI":"10.1186\/s12920-023-01682-w"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13816810.2023.2289449","article-title":"PHARC syndrome which an ultra-rare syndrome with retinitis pigmentosa and cataracts: Case report and review of the literature","volume":"45","author":"Demir","year":"2024","journal-title":"Ophthalmic Genet."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Long, X., Xiong, W., Wang, X., Geng, J., Zhong, M., Huang, Y., Liu, M., Bu, F., Cheng, J., and Lu, Y. (2024). Genotype-phenotype spectrum and correlation of PHARC Syndrome due to pathogenic ABHD12 variants. BMC Med. Genom., 17.","DOI":"10.1186\/s12920-024-01984-7"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e70055","DOI":"10.1002\/mgg3.70055","article-title":"A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype","volume":"13","author":"Ma","year":"2025","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI90727","article-title":"Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency","volume":"127","author":"Cottineau","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1194\/jlr.M030411","article-title":"Biochemical and pharmacological characterization of human \u03b1\/\u03b2-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)","volume":"53","author":"Savinainen","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)80542-5","article-title":"A Perfect Message: RNA Surveillance Minireview and Nonsense-Mediated Decay","volume":"96","author":"Hentze","year":"1999","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/hmg\/ddz028","article-title":"Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics","volume":"28","author":"Sarkar","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI132990","article-title":"Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trial","volume":"130","author":"Campochiaro","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Campofelice, A., Lentini, L., Di Leonardo, A., Melfi, R., Tutone, M., Pace, A., and Pibiri, I. (2019). Strategies against nonsense: Oxadiazoles as translational readthrough-inducing drugs (TRIDs). Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133329"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1002\/wrna.1739","article-title":"Mammalian proteome expansion by stop codon readthrough","volume":"14","author":"Manjunath","year":"2022","journal-title":"Wiley Interdiscip. Rev. RNA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:52:41Z","timestamp":1787327561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":42,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167506"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167506","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}